Chemtura (CHMT) Misses Q4 EPS by 7c

Chemtura (NYSE: CHMT) reported Q4 EPS of $0.34, $0.07 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $385 million versus the consensus estimate of $386.47 million.

For earnings history and earnings-related data on Chemtura (CHMT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance